s6y

NxStage Medical, Inc.

CIK
1333170
Industry
Electromedical & Electrotherapeutic Apparatus
Based in
Lawrence, Massachusetts
Incorporated in
Delaware
Fiscal year ends
December 31
SEC filer category
Large accelerated filer
Employer ID (EIN)
04-3454702

Key figures

Fiscal year to Dec 2017 Dec 2016 Dec 2015 Dec 2014 Dec 2013
Revenue –––$301.5M$263.4M
Operating income −$13.9M−$4.29M−$14.6M−$22.2M−$17.8M
Net income −$14.0M−$4.77M−$15.3M−$23.9M−$18.6M
Diluted EPS −$0.22−$0.07−$0.24−$0.39−$0.31
Cash from operations $4.80M$4.59M$10.5M−$20.3M−$10.1M
Total assets $325.6M$317.2M$306.9M$309.7M$307.0M
Shareholders’ equity $213.2M$201.4M$191.8M$190.5M$194.2M

From the company’s annual reports to the SEC. Each year links to its report.

Financials 58

  1. 10-Q Quarterly Report for period ending Sep 30, 2018
  2. 10-Q Quarterly Report for period ending Jun 30, 2018
  3. 10-Q Quarterly Report for period ending Mar 31, 2018
  4. 10-K Annual Report for period ending Dec 31, 2017
  5. 10-Q Quarterly Report for period ending Sep 30, 2017
  6. 10-Q Quarterly Report for period ending Jun 30, 2017
  7. 10-Q Quarterly Report for period ending Mar 31, 2017
  8. 10-K Annual Report for period ending Dec 31, 2016
  9. 10-Q Quarterly Report for period ending Sep 30, 2016
  10. 10-Q Quarterly Report for period ending Jun 30, 2016

All 58 financials filings

News 126

  1. 8-K Material agreement ended; Acquisition or sale completed; Delisting notice; Change to shareholder rights; Change in control; Director or officer change; Charter or bylaw change
  2. 8-K Material agreement
  3. 8-K Material agreement
  4. 8-K Material agreement
  5. 8-K Other events
  6. 8-K Shareholder vote results
  7. 8-K Shareholder vote results
  8. 8-K Other events
  9. 8-K Shareholder vote results
  10. 8-K Material agreement; Financial results; Director or officer change; Charter or bylaw change; Regulation FD disclosure

All 126 news filings

Ownership 1,134

  1. SC 13G/A Major shareholder report (passive investor)
  2. 4 Change in insider ownership
  3. 4 Change in insider ownership
  4. 4 Change in insider ownership
  5. 4 Change in insider ownership
  6. 4 Change in insider ownership
  7. 4 Change in insider ownership
  8. 4 Change in insider ownership
  9. 4 Change in insider ownership
  10. 4 Change in insider ownership

All 1,134 ownership filings

Prospectus 49

  1. S-8 POS Post-effective amendment to a S-8 registration statement
  2. S-8 POS Post-effective amendment to a S-8 registration statement
  3. S-8 POS Post-effective amendment to a S-8 registration statement
  4. S-8 POS Post-effective amendment to a S-8 registration statement
  5. S-8 POS Post-effective amendment to a S-8 registration statement
  6. S-8 POS Post-effective amendment to a S-8 registration statement
  7. S-8 POS Post-effective amendment to a S-8 registration statement
  8. S-8 POS Post-effective amendment to a S-8 registration statement
  9. S-8 POS Post-effective amendment to a S-8 registration statement
  10. S-8 Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

All 49 prospectus filings

Proxies 26

  1. DEF 14A Definitive proxy statements
  2. DEFM14A Definitive proxy statement relating to a merger, acquisition, or disposition
  3. PREM14A Preliminary proxy statement relating to a merger, acquisition, or disposition
  4. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  5. DEFA14A Definitive additional proxy soliciting materials including Rule 14(a)(12) material. Note: Submission type DEFA14A can be filed as part of Form 8-K. For filers subject to 8-K filing requirements, we recommend the use of the 8-K combined form type as the easiest method for fulfilling your filing requirement for both forms.
  6. DEF 14A Definitive proxy statements
  7. PRE 14A Preliminary proxy statement not related to a contested matter or merger/acquisition
  8. DEF 14A Definitive proxy statements
  9. DEF 14A Definitive proxy statements
  10. DEF 14A Definitive proxy statements

All 26 proxies filings

Other 92

  1. CT ORDER Order Granting Confidential Treatment
  2. CT ORDER Order Granting Confidential Treatment
  3. CT ORDER Order Granting Confidential Treatment
  4. CT ORDER Order Granting Confidential Treatment
  5. CT ORDER Order Granting Confidential Treatment
  6. CT ORDER Order Granting Confidential Treatment
  7. CT ORDER Order Granting Confidential Treatment
  8. 15-12G Notice of termination of registration of a class of securities under Section 12(g)
  9. 25-NSE Removal from exchange listing
  10. CT ORDER Order Granting Confidential Treatment

All 92 other filings